GLAS Glass House Brands Inc.

NYSE
$1.27

Glass House Faces a Proof Test on Costs, Cash and Schedule III Supply Deals After Stock Collapse

Glass House Brands heads into its third-quarter report with a striking disconnect. Last quarter, management described a farm that was clearly healing, with record biomass, wholesale prices above plan and adjusted EBITDA swinging back into positive territory. Yet the stock has since fallen about 87%, trading near $1.27, far beneath its 200-day moving average of $7.40, while the S&P 500 slipped only about 3%. Whatever the market is pricing in, it is not the recovery story management told. The November 16 report, due after the close, needs to show whether that story still holds.

The Street is looking for revenue of about $50.5 million and a loss of roughly $0.13 per share. That revenue figure implies modest sequential growth from the $47.6 million reported last quarter, a reasonable bar given that retail stores are now deconsolidated and no longer pad the top line. The prior quarter's per-share result is not a useful anchor for comparison, so the operating details matter far more than the headline EPS. There is also no management outlook to measure against. The company withdrew its full-year targets for revenue, gross profit, EBITDA and ending cash last quarter and did not replace them, leaving analysts to estimate without guardrails. Any return of formal guidance, even a narrow one, would help close that visibility gap.

The operating checklist comes straight from the last call. Cost of production fell from $175 per pound to $122, and management said it expects to exit the year below $100 on the way to a long-term target of $95. A third-quarter figure moving clearly toward that level would validate the cost narrative; stalling near $120 would challenge it. Gross margin is the other pressure point. It came in at 34%, well short of the high-40s level management had pointed to and far below the 55% of a year earlier, held back by a heavy mix of lower-value trim tied to source strains, a largely new workforce and an offline co-generation unit that supplies most of the greenhouse CO2. Investors should want evidence that the co-gen is back, that trim mix is improving and that crews are getting more experienced. Wholesale pricing of $211 per pound also beat expectations last quarter, so holding near that level would confirm that California pricing firmness is real rather than seasonal.

The bigger strategic question is whether Schedule III is turning from talk into contracts. Glass House is DEA-registered, fully medically licensed, now free of 280E on medical sales going forward, and has hired a compliance group led by a former senior DEA official to build export and interstate channels. Management said it expected multiple supply agreements before year-end, with international shipments likely first. Signed deals, or at least concrete timelines, would give real substance to that optionality. Silence would make the narrative look increasingly speculative, especially with hemp sales still at an early stage and facing regulatory uncertainty.

Cash is where the downside risk sits. Operating cash flow last quarter was just $139,000, cash ended at $22 million, and the balance sheet still carries a $38 million uncertain tax provision. Funding has leaned on the at-the-market program and warrant proceeds. Sentiment has turned from mildly bullish before the last report to mildly bearish now, which fits a market worried more about the balance sheet than about growth.

In the end, the report comes down to whether better farm economics can begin producing cash on their own. Falling costs, recovering margins and real Schedule III contracts would suggest the selloff went too far. Another quarter of thin cash generation without guidance or signed deals would give skeptics plenty of reason to stay put.

← Back to GLAS news